EverSource Wealth Advisors’s Emergent Biosolutions EBS Stock Holding History

EverSource Wealth Advisors’s Portfolio EBS Stock Details EBS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$8.29K	Buy	989 +195	+25%	+$1.63K	﹤0.01%	3016
2026 Q1	$6.59K	Buy	794 +68	+9%	+$704	﹤0.01%	3129
2025 Q4	$8.97K	Buy	726 +143	+25%	+$1.53K	﹤0.01%	2855
2025 Q3	$5.14K	Buy	583 +383	+192%	+$2.98K	﹤0.01%	3137
2025 Q2	$1.28K	Buy	200 +114	+133%	+$652	﹤0.01%	3667
2025 Q1	$418	Buy	+86	New	+$712	﹤0.01%	3517
2024 Q1	–	Sell	-210	Closed	-$504	–	2920
2023 Q4	$504	Buy	+210	New	+$494	﹤0.01%	2523
2023 Q3	–	Sell	-206	Closed	-$1.51K	–	2546
2023 Q2	$1.51K	Buy	+206	New	+$1.91K	﹤0.01%	2104
2023 Q1	–	Sell	-443	Closed	-$5.23K	–	2420
2022 Q4	$5.23K	Buy	443 +151	+52%	+$2.34K	﹤0.01%	1583
2022 Q3	$6K	Buy	292 +103	+54%	+$2.87K	﹤0.01%	1285
2022 Q2	$6K	Buy	+189	New	+$6.45K	﹤0.01%	1192

Other funds holding EBS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

OHA

Oak Hill Advisors New York $701M AUM 78.4% 1-Year Est. Return

EverSource Wealth Advisors's EBS Position: Q2 2026 in Review

EverSource Wealth Advisors increased its Emergent Biosolutions (EBS) stake by 25% in Q2 2026, buying an estimated $1.63K and bringing the position to 989 shares worth $8.29K. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

EverSource Wealth Advisors first reported a position in EBS in Q2 2022 and has held it in 11 quarters since. The position peaked at $8.97K in Q4 2025. 194 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

EverSource Wealth Advisors held 989 shares of Emergent Biosolutions worth $8.29K as of Q2 2026.
EverSource Wealth Advisors bought 195 Emergent Biosolutions shares in Q2 2026, an estimated $1.63K.
Emergent Biosolutions made up ﹤0.01% of EverSource Wealth Advisors's portfolio in Q2 2026, its #3016 holding.
EverSource Wealth Advisors first reported a position in Emergent Biosolutions in Q2 2022 and has held it in 11 quarters since.
EverSource Wealth Advisors's Emergent Biosolutions position peaked at $8.97K in Q4 2025.
194 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on EverSource Wealth Advisors's 13F filing for Q2 2026, filed 24 Jul 2026.